Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Gail Tomlinson, MD, PhD

Contact

210-567-7477

tomlinsong@uthscsa.edu

For administrative calls, please contact:

Departments & Divisions

Institutes & Centers

Gail Tomlinson, M.D., Ph.D.

Division Chief, Pediatrics Hematology/Oncology

Co-Director, Population Science Program and Prevention

Greehey Distinguished Chair in the Genetics of Cancer

I am a pediatric cancer specialist with specific expertise in inherited cancer syndromes which affect children and adults.  In addition to providing care for children with cancer, I work with individuals and families who are at higher than average risk of cancer to provide personalized longitudinal surveillance plans to decrease risk or enhance early detection.  I also have a long -standing interest in pediatric liver tumors and rare cancers.

  • Professional Background

    Education

    • 1992 - Postdoctoral Fellowship - Pediatrics-Hematology/Oncology - University of Texas Southwestern Medical Center
    • 1989 - Postdoctoral Fellowship - Pediatrics-Hematology/Oncology - University of Texas M.D. Anderson Cancer Center
    • 1987 - Residency - Pediatrics - Children's Hospital National Medical Center
    • 1984 - MD - Medicine - George Washington University Medical School
    • 1982 - PhD - Biochemistry - Duke University
    • 1974 - BS - Biology (Summa Cum Laude) - Dickinson College

    Appointments

    • 1/2007 - Professor with Tenure - University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio
    • 1/2007 - Division Chief, Pediatrics Hematology/Oncology - University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio

  • Instruction & Training

    • 04/2007 - 12/2012, MEDI6067 Genetics and Genetic Epidemiology, UT Health San Antonio
    • 03/2007 - 04/2016, CSBL6069 Cancer Biology Core II, UT Health San Antonio
    • 11.2018 - present, Team-Based Learning - Cancer Genetic Counseling, UT Health San Antonio
    • 09/2017 - present, CIRC5007 Inherited Cancer Lecture (MS1) , UT Health San Antonio
    • 09/2017 - present, GSBS TSCI16067 Cancer Genetics , UT Health San Antonio
    • 09/2017 - present, CIRC5007 Mock Tumor Board (MS1) , UT Health San Antonio
    • 08/2017 - 09/2019 , UTRGV: Ethics and Genetics Panel Leader (MS1) , UT Health San Antonio
    • 2012 - present, Associate Director, Pediatric Hematology/Oncology Fellowship Program, UT Health San Antonio

  • Publications

      Journal Articles

      1. Vucolo B, B  Gutierrez AM, Robinson JO,, Recinos AM, Desrosiers LR, Majumder MA, Bernini JC,  Gill J ,Griffin T, Tomlinson GE, Vallance K, McGuire AL,  Parsons DW, Plon SE, Scollon S.  Participant Experiences Accessing Follow-Up Care after Receipt of Significant Germline Results in the Texas KidsCanSeq Study, J. Genetic Counseling, published online Jan 15, 2024. PMID: 38225886.
      2. He F, Bandyopadhyay AM, Klesse L, Rogojina A,  Chun SH, Butler E, Hartshorne T, Holland T, Garcia D, Weldon K, Perez Prado L, Langevin AM, Grimes AC, Sugalski A, Shah S, Assanasen C, Lai A, Zou Y, Kurmashev D, Xu L, Xie Y, Chen Y, Wang X. Tomlinson GE, Skapek SX, Kurmasheva R, Houghton PJ, Zheng S. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer, Nature Commun, 2023 Nov 22;14(1):7600. PMID:37990009.
      3. Rogojina A, Klesse L, Butler E, Kim J, Zhang H, Xiao X, Guo L, Zhou Q, Hartshorne T, Garcia D, Weldon K, Holland T, Bandyopadhyay A,  Perez Prado L, Wang S, Yang D, Langevin AM, Grimes AC, Assanasen C, Gidvani-Diaz,V, Zheng S, Zhou Y, Lai Z, Chen Y,  Xie Y, Tomlinson GE, Skapek SX,  Kurmasheva RT, Houghton PJ, Xu L. Comprehensive characterization of patient-derived xenograft models of pediatric leukemia. iScience, 2023, 26 (11): 108192. PMID: 37915590.
      4. Chen J, Baxi K, Lipsitt AE, Hensch NR, Wang L, Baudin A, Robledo DG, Bandyopadhyay A, Sugalski A, Challa AK, Gilbert AR, Tomlinson GE, Houghton P, Chen EY, Libich DS, Ignatius M. Defining function of wild-type and three patient-specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma. ELife 2023 12 :e68221. PMID : 37266578.
      5. Wu S, Lui Y, Williams M, Aguilar C, Ramirez AG, Mesa R, Tomlinson GE. Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study ; PLoS One 2023 18(4):e0278354 2023 PMID: 3702291.
      6. Soewito S, Wyatt R, Berenson E, Poullard N, Gessay S, Mette L, Marin E, Shelby K, Alvarez E, Choi, BY, Aviles C, Pulido-Saldivar AM, Otto PM, Jatoi I, Ignatius M. Ramamurthy C, Kaklamani VG, Tomlinson GE, Disparities in cancer genetic Ttesting and variants of uncertain significance in the Hispanic population of South Texas, JCO Oncology Practice, 2022 18(5):e805-e811. PMID 35544645. 
      7. Gutierrez AM, Robinson JO, Outram SM, Smith HS, Kraft SA Donohue KE, Biesecker BB, Brothers KB, Chen F, Hailu B,  Hindorff LA, Hoban H, Hsu RL, Knight SJ, Koenig BA, Lewis  KL, O’Daniel JM, Okuyama S, Tomlinson GE, Waltz M, Wilfond BS, Ackerman SL, Majumder MA.  Examining Access to Care in Clinical Genomic Research: Experiences from the Clinical Sequencing Evidence-Generating Research (CSER) Consortium. Journal of Clinical and Translational Science, 5(1) : e193, 1-15. 34888063.
      8. Lipsitt A, DeForest P, Canon A, Gibson A, Tomlinson GE. When Tumor Becomes Legacy: A collection of Perspectives, J. Palliative Medicine, 2021 24(10):  1572-1574. PMID: 34596468.
      9. Sybouts, EH, Brown, AD, Falcon-Cantrill M, Thomas, M, DeNapoli, T, Voeller, J, Chen Y, Tomlinson G*, Bishop AJ. Bloom syndrome in a Mexican American family with rhabdomyosarcoma: evidence of a Mexican founder mutation. Cold Spring Harbor Molecular Case Studies 2021 Apr 8;7(2):a005751.  (*Corresponding author) PMID: 33832920.

  • Clinical

    Board Certifications

    • 1992 - Hematology-Oncology - American Board of Pediatrics
    • 1988 - General Pediatrics - American Board of Pediatrics